Literature DB >> 19494610

Insights on peritoneal dialysis-related infections.

Beth Piraino.   

Abstract

Peritonitis remains a serious complication of peritoneal dialysis and can lead to death of the patient. Most peritonitis is due to either contamination with the peritoneal dialysis exchange or exit site infection and can be prevented by protocols for appropriate training and exit site care. The micro-organism infecting the peritoneum is an important clue to the etiology: coagulase-negative Staphylococcus is generally due to touch contamination while Pseudomonas aeruginosa and Staphylococcus aureus are most often due to catheter infections. The etiology of other Gram-negative peritonitis is uncertain but appears to relate to bowel problems especially constipation, hypokalemia, perhaps leading to dysmotility, as well as touch contamination at the time of the exchange. The approach to treating peritonitis is always to rapidly resolve the infection, even if this entails removing the peritoneal catheter. Refractory peritonitis is generally defined as peritonitis treated with an appropriate antibiotic for fi ve days without evidence of resolution. The antibiotic to treat peritonitis should be chosen based on the past history of the organisms and sensitivities of the program, should cover Gram-negative and Gram-positive organisms, and tailored once the cause is identified. Relapsing peritonitis requires catheter exchange. Each program should have continuous quality improvement that tracks each episode, performing root cause analysis, examining organisms, rates of organisms, and outcome. In this way, each program can develop initiatives to lower peritonitis rates. Such protocols might include the use of routine exit site antibiotic cream as part of daily care, re-training of patients, prevention of constipation, and removal of infected catheters. With an aggressive approach peritonitis rates can be lowered to very low rates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494610     DOI: 10.1159/000223795

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  7 in total

Review 1.  A qualitative systematic review of the literature supporting a causal relationship between exit-site infection and subsequent peritonitis in patients with end-stage renal disease treated with peritoneal dialysis.

Authors:  Anouk T N van Diepen; Sarbjit V Jassal
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

2.  The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.

Authors:  Anouk T N van Diepen; George A Tomlinson; Sarbjit V Jassal
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

3.  The impact of the superficial cuff position on the exit site and tunnel infections in CAPD patients.

Authors:  Luca Nardelli; Antonio Scalamogna; Piergiorgio Messa
Journal:  J Nephrol       Date:  2020-07-09       Impact factor: 3.902

4.  Benefit of an operating vehicle preventing peritonitis in peritoneal dialysis patients: a retrospective, case-controlled study.

Authors:  Pan Fang; Jia Lu; Ying-Hong Liu; Hong-Mei Deng; Lei Zhang; Hong-Qing Zhang
Journal:  Int Urol Nephrol       Date:  2018-03-05       Impact factor: 2.370

5.  Association between keeping home records of catheter exit-site and incidence of peritoneal dialysis-related infections.

Authors:  Hidekazu Iida; Noriaki Kurita; Shino Fujimoto; Yuka Kamijo; Yoshitaka Ishibashi; Shingo Fukuma; Shunichi Fukuhara
Journal:  Int Urol Nephrol       Date:  2018-01-18       Impact factor: 2.370

6.  Actinomyces peritonitis: removal of the peritoneal catheter unnecessary for resolution.

Authors:  R Díaz; M A Bajo; G Del Peso; A García-Perea; R Sánchez-Villanueva; R Selgas
Journal:  NDT Plus       Date:  2010-03-05

7.  Comparison of Exit-Site Infection Frequency in Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients: A Single-Center Experience.

Authors:  Mustafa Sevinç; Nuri Barış Hasbal; Elbis Ahbap; Yener Koç
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-09-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.